Sign in

CIK 0001622229 · Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465308248
Phone
617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
  1. 8-K Event Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. EFFECT Other Notice of Effectiveness
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 424B5 Offering Prospectus
  7. POS AM Other Post-effective Amendment for Registration Statement
  8. ARS Other Annual Report to Security Holders
  9. DEFA14A Proxy Proxy Materials
  10. DEF 14A Proxy Proxy Statement
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. PRE 14A Proxy Proxy Statement (Preliminary)
  13. 4 Derivatives Options or other derivatives
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 10-K Report Annual Report
  16. 8-K Event Results of operations
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. 4 Derivatives Options or other derivatives

Page 6 of 31 · 616 filings